Clinical trial Recruiting at 1 site Observational Ages 50 to 90

Impact of Phaco Tip Location on Early Postoperative Outcomes in Cataract Surgery

Official title: The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

Run by Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07550907 · Data updated 2026-11-12

This observational study tests whether the position of the phacoemulsification tip during cataract surgery affects early changes in the cornea and vision in people with age-related cataracts.

Quick facts

Study typeObservational
Ages50 Years to 90 Years
SexAll
Enrollment300 (estimated)
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedApril 20, 2026
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedJune 3, 2026
Trial IDNCT07550907 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 50–90 years with unilateral or bilateral age-related cataract, scheduled for phacoemulsification with IOL and meeting all ocular health criteria (LOCS III nuclear grade ≥2, pupil ≥6 mm after dilation, endothelial cell count ≥1500 cells/mm²).

Probably not a fit

Patients with other ocular diseases, complicated anatomy, or comorbidities may not experience a benefit from tip-position findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study involving adults aged 50 to 90 undergoing phacoemulsification with intraocular lens implantation. Intraoperative OCT will be used to document the phaco tip location (supracapsular, iris-lens diaphragm, or endocapsular) during surgery. Postoperative assessments will measure corneal changes and visual acuity at an early timepoint to explore potential associations with tip position. The study aims to identify if specific tip locations correlate with better immediate postoperative corneal status and vision. No intervention beyond standard cataract surgery and imaging is planned.

Why it matters

Potential benefit: If a link is found, surgeons may optimize phaco tip position to improve early postoperative corneal health and visual outcomes.

How similar studies have gone: Prior work has explored intraoperative variables affecting outcomes, but using intraoperative OCT to correlate phaco tip location with early corneal/visual outcomes is a novel approach with limited prior success data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 50 years and ≤ 90 years
* Diagnosis of unilateral/bilateral age-related cataract
* Nuclear grade ≥2 in LOCSIII classification
* Scheduled for cataract phacoemulsification combined with intraocular lens implantation
* Pupil size ≥6mm after dilation
* Corneal endothelial cell count ≥1500 cells/mm²

Exclusion Criteria:

* Diagnosis of severe systemic disease (e.g., severe hypertension or Alzheimer's disease)
* History of ocular trauma or surgery
* Presence of other ocular diseases (such as glaucoma, diabetic retinopathy, or high myopia)
* Other ocular factors that may complicate the surgery (such as small pupil, shallow anterior chamber)

Where it's running

  • Zhongshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.